COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,803 Articles (22,527 medRxiv, 8,276 bioRxiv)

Most recent first Previous |  Page 2306: Articles 23051-23060  | Next

Rates of COVID-19-related Outcomes in Cancer compared to non-Cancer Patients
Sun, L., Sanjna, S., Le, A., Desai, H., Doucette, A., Gabriel, P., Ritchie, M., Rader, D., Maillard, I., Bange, E., Huang, A., Vonderheide, R. H., DeMichele, A., Verma, A., Mamtani, R., Maxwell, K. N.
10.1101/2020.08.14.20174961 — Posted: 2020-08-16
Pre-COVID-19 humoral immunity to common coronaviruses does not confer cross-protection against SARS-CoV-2
Miyara, M., Sterlin, D., Anna, F., Marot, S., Mathian, A., Atif, M., Quentric, P., Mohr, A., Claer, L., Dorgham, K., Parizot, C., Yssel, H., Chazal, T., Fadlallah, J., Haroche, J., Benameur, N., Boutolleau, D., Burrel, S., Mudumba, S., Hockett, R., Genalyte, C., Charneau, P., Calvez, V., Marcelin, A.-G., Amoura, Z., Gorochov, G.
10.1101/2020.08.14.20173393 — Posted: 2020-08-15 Discussion: Onsite | Offsite
Covid-19 related stress and coping strategies among adults with chronic disease in Southwest Ethiopia.
Girma, A., Ayalew, E.
10.1101/2020.08.14.20174318 — Posted: 2020-08-15
Outcomes of Persons With COVID-19 in Hospitals With and Without Standard Treatment With (Hydroxy)chloroquine
Peters, E. J., Collard, D., van Assen, S., Beudel, M., Bomers, M. K., Buijs, J., de Haan, L., de Ruijter, W., Douma, R., Elbers, P. W., Goorhuis, A., Gritters van den Oever, N. C., Knarren, G. H., Moeniralam, H. S., Mostard, R. L., Quanjel, M. J., Reidinga, A. C., Renckens, R., van den Bergh, J. P., Vlasveld, I. N., Sikkens, J. J.
10.1101/2020.08.14.20173369 — Posted: 2020-08-15 Discussion: Onsite
Abusers indoors and coronavirus outside: an examination of public discourse about COVID-19 and family violence on Twitter using machine learning
Xue, J., Chen, J., Chen, C., Hu, R., Zhu, T.
10.1101/2020.08.13.20167452 — Posted: 2020-08-15
An Analysis of Self-reported Longcovid Symptoms on Twitter
Singh, S. M., Reddy, C.
10.1101/2020.08.14.20175059 — Posted: 2020-08-15
Modelling Suggests Limited Change in the Reproduction Number from Reopening Norwegian Kindergartens and Schools During the COVID-19 Pandemic
Rypdal, M., Rypdal, V. G., Jakobsen, P. K., Ytterstad, E., Lovsletten, O., Klingenberg, C., Rypdal, K.
10.1101/2020.08.14.20174896 — Posted: 2020-08-15
Dynamical balance between the transmission, intervention of COVID-19 and economic development
Zhang, Z., Lin, H., Zhu, G.
10.1101/2020.08.13.20174755 — Posted: 2020-08-15
Stethoscope and Non-Infrared Thermometer Disinfection among Physicians: A Cross-Sectional Study with Implications for the Control of COVID-19
Sahiledengle, B., Tekalegn, Y., Bekele, K., Tesemma, A., Edward Quisido, B. J.
10.1101/2020.08.14.20174433 — Posted: 2020-08-15
England's Lockdown vs. Sweden's Herd Immunity: A Comparison of the Daily New COVID-19 Cases and Related Deaths Using Comparative Interrupted Time Series Analysis
Mustafa Ali, M., Samhouri, Y., Sabha, M., Alnimer, L.
10.1101/2020.08.13.20174706 — Posted: 2020-08-15 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).